ResMed Inc (NYSE:RMD)
$ 234.42 1.84 (0.79%) Market Cap: 34.14 Bil Enterprise Value: 34.57 Bil PE Ratio: 30.81 PB Ratio: 6.57 GF Score: 99/100

Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 05:15PM GMT
Release Date Price: $295.58 (-0.60%)
Sean M. Laaman
Morgan Stanley, Research Division - Australian Healthcare Analyst

Good afternoon, everybody, and welcome to Morgan Stanley's Global Healthcare Conference of 2021. Before we commence for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. With that complete, we welcome today from ResMed, the CEO, Mick Farrell; and Dave Pendarvis, Global General Counsel and Chief Administrative Officer. I thank you for your time today, gentlemen. Greatly appreciated.

Questions & Answers

Sean M. Laaman
Morgan Stanley, Research Division - Australian Healthcare Analyst

Let's jump straight in. And first thing that seems to be at the forefront of investors' minds is the AirSense 11. What's the timing of the launch? What are the features versus the AirSense 10? And how does it fit into the ResMed ecosystem

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot